Divergent Modes of Enzyme Inhibition in a Homologous Structure−Activity Series

A docking screen identified reversible, noncovalent inhibitors (e.g., 1) of the parasite cysteine protease cruzain. Chemical optimization of 1 led to a series of oxadiazoles possessing interpretable SAR and potencies as much as 500-fold greater than 1. Detailed investigation of the SAR series subseq...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 52; no. 16; pp. 5005 - 5008
Main Authors Ferreira, Rafaela S, Bryant, Clifford, Ang, Kenny K. H, McKerrow, James H, Shoichet, Brian K, Renslo, Adam R
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 27.08.2009
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A docking screen identified reversible, noncovalent inhibitors (e.g., 1) of the parasite cysteine protease cruzain. Chemical optimization of 1 led to a series of oxadiazoles possessing interpretable SAR and potencies as much as 500-fold greater than 1. Detailed investigation of the SAR series subsequently revealed that many members of the oxadiazole class (and surprisingly also 1) act via divergent modes of inhibition (competitive or via colloidal aggregation) depending on the assay conditions employed.
Bibliography:NIH RePORTER
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm9009229